BioCentury | Feb 25, 2020
Finance

Feb. 24 Financial Quick Takes: Bio-Thera shines in first days on STAR; plus ImmuneOnco, GenCells, Twist and Axovant

...Fc fusion which binds both CD47 and CD20 for non-Hodgkin lymphoma. GenCells raises pre-A round GenCells Therapeutics Co. Ltd....
...sale of 19.9 million shares and pre-funded warrants at $3.75 apiece. Hongjiang Li, Staff Writer Twist Bioscience Corp. GenCells Therapeutics Co. Ltd. Axovant...
Items per page:
1 - 1 of 1
BioCentury | Feb 25, 2020
Finance

Feb. 24 Financial Quick Takes: Bio-Thera shines in first days on STAR; plus ImmuneOnco, GenCells, Twist and Axovant

...Fc fusion which binds both CD47 and CD20 for non-Hodgkin lymphoma. GenCells raises pre-A round GenCells Therapeutics Co. Ltd....
...sale of 19.9 million shares and pre-funded warrants at $3.75 apiece. Hongjiang Li, Staff Writer Twist Bioscience Corp. GenCells Therapeutics Co. Ltd. Axovant...
Items per page:
1 - 1 of 1